Jim Melton, DO
Vascular Surgery · Oklahoma City, OKNPI 1093702011
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (37.8%), other and consulting fees — rather than concentrated in one kind of arrangement. 49 manufacturers reported payments, led by Philips North America LLC at 35.2% of the total. Reporting peaked in 2019 at $45,862 and has fallen 75.7% since, to $11,166 in 2025. Among vascular surgery clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 435 payments — averaging $300.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$46K
- Angiodynamics, Inc.$46K
- Boston Scientific$11K
- Terumo Medical Corporation$9K
- Abbott$6K
- Shockwave Medical, Inc$4K
- plus $10K from 43 others
Across 21 payments — averaging $758.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$16K
- Silk Road Medical, Inc.$375
What the payments were for
- Consulting fees$19,14815%
- Speaking & faculty fees$49,45338%
- Travel & lodging$1,0071%
- Food & beverage$15,58912%
- Education$14,40011%
- Other$31,32024%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VenaCure 1470 Pro$36,120
- IGT D Peripheral$30,095
- EVLT$9,600
- Navicross$8,619
- Glidesheath$8,619
- GlideWire$8,619
- JETSTREAM SC$8,600
- (9520) IGT Devices Undivided$4,763
- Supera peripheral stent system$4,634
- IGT Devices Und$3,580
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$3,131
- Spectranetics Undiv$2,520
- ENROUTE Transcarotid Neuroprotection System$2,002
- ENROUTE Transcarotid Stent System$1,485
- ENHANCE Transcarotid Peripheral Access Kit$1,485
- ENROUTE 0.014 Guidewire$1,485
- Educ Ultrasound$1,348
- GENERAL VASCULAR INTERVENTION$1,151
- IVUS Systems$975
- Turbo Elite$574
How this compares
$130,916 in reported general payments places this provider in the 90th percentile of 35 vascular surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 27 | $24,904 |
| EliquisApixaban | 19 | $14,604 |
| ClopidogrelClopidogrel Bisulfate | 359 | $5,615 |
| Prasugrel Hcl | 33 | $3,718 |
| Cilostazol | 126 | $2,675 |
| Gabapentin | 132 | $2,610 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 134 | $1,687 |
| Amitriptyline Hcl | 35 | $532 |
| Doxycycline Hyclate | 36 | $344 |
| Pregabalin | 17 | $285 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $205 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 19 | $131 |
| Nifedipine ErNifedipine | 13 | $126 |
| Meclizine Hcl | 12 | $125 |
| Ciprofloxacin Hcl | 14 | $100 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $1,340 | $24,90427 claims |
| PfizerEliquis | $14 | $14,60419 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 35 vascular surgery providers in Oklahoma.
Other vascular surgery in Oklahoma City
- Lenny StubbsOklahoma City$56K
- Ali AminOklahoma City$41K
- Bernardino RochaOklahoma City$34K
- Clifford HowellOklahoma City$17K
- Sherisa WarrenOklahoma City$15K
- Jones ThomasOklahoma City$14K
- Trenton KinnearOklahoma City$10K
- Donald SpadoneOklahoma City$9K
- James NeelOklahoma City$7K
- Whitney ThorneOklahoma City$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.